Novartis named Mike Ball as new division head at Alcon. Ball joins Novartis from Hospira, where he was CEO from 2011 until recently.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
80.08 CHF | -0.99% | +7.72% | +22.00% |
May. 17 | Moody’s Upgrades Alcon on Strong Financial Performance | MT |
May. 15 | Stifel Adjusts Price Target on Alcon to $100 From $95, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.00% | 43.62B | |
+15.42% | 103B | |
+2.75% | 19.34B | |
-15.81% | 2.35B | |
+18.37% | 1.96B | |
+28.12% | 1.22B | |
-34.35% | 757M | |
-3.25% | 683M | |
-40.44% | 680M | |
+25.05% | 518M |
- Stock Market
- Equities
- ALC Stock
- News Alcon Inc.
- Alcon Names Mike Ball as New Division Head